Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
The University Court of the University of Edinburgh currently manages 8 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed among 8 distinct examiners, resulting in a decentralized prosecution environment. The active cases are further spread across 6 distinct art units, indicating a technical footprint within the biotechnology sector.
CELESTINE, NYROBI I is the busiest examiner for the university, currently handling 1 pending office action. Because 8 distinct examiners are each managing a case, the university's legal representatives must coordinate with a wide array of individuals at the patent office. The involvement of 6 distinct art units suggests that the portfolio covers a variety of specialized biological or pharmaceutical innovations. This diversity in both examiners and art units requires a versatile approach to addressing office actions, as each of the 8 matters is subject to different examiner perspectives.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (11%) |
| §103 only | 1 (11%) |
| §112 only | 2 (22%) |
| Multi-statute (no §101) | 5 (56%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BUI, ANDREW THANH | 1 | 80.7% | +9.0% |
| CELESTINE, NYROBI I | 1 | 81.4% | +23.1% |
| CHERRY, EUNCHA P | 1 | 88.1% | +9.4% |
| BURKHART, MICHAEL D | 1 | 62.3% | +11.7% |
| PULLEN, NIKOLAS TAKUYA | 1 | 52.5% | +8.4% |
| BOWLES, DAVID PAUL | 1 | 72.7% | +22.4% |
| JOHANSEN, PETER N. | 1 | 59.3% | +24.4% |
| MCANANY, JOHN D | 1 | 67.2% | +43.7% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.7% | +41.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19472202 | TURBINE BLADE | BUI, ANDREW THANH | — |
| 18875528 | Fluid Monitoring System | CELESTINE, NYROBI I | — |
| 18866736 | IMAGING DEVICE AND IMAGING SYSTEM | CHERRY, EUNCHA P | — |
| 18580909 | METHOD OF SELECTIVE PRECIPITATION OF METALS USING AMIDE COMPOUNDS | PULLEN, NIKOLAS TAKUYA | — |
| 18568921 | GRANZYME B DETECTION | BOWLES, DAVID PAUL | — |
| 18274306 | FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD | JOHANSEN, PETER N. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18875528 | Fluid Monitoring System | CELESTINE, NYROBI I | — |
| 18690014 | GENETIC RESISTANCE TO VIRAL DISEASE IN SALMONID FISH | BURKHART, MICHAEL D | — |
| 18568921 | GRANZYME B DETECTION | BOWLES, DAVID PAUL | — |
| 18274306 | FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD | JOHANSEN, PETER N. | — |
| 18010440 | ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE, PIOGLITAZONE OR ROSIGLITAZONE | MCANANY, JOHN D | — |
| 17638542 | PARASITIC NEMATODE VACCINE | OGUNBIYI, OLUWATOSIN A | — |
| Art Unit | Apps |
|---|---|
| 3745 | 1 |
| 1638 | 1 |
| 1733 | 1 |
| 1653 | 1 |
| 1644 | 1 |
| 1625 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19472202 | TURBINE BLADE | BUI, ANDREW THANH | 3745 | §102§103 | Non-Final OA | — | Pending | Oct 03, 2025 |
| 18875528 | Fluid Monitoring System | CELESTINE, NYROBI I | — | §102§103§112 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18866736 | IMAGING DEVICE AND IMAGING SYSTEM | CHERRY, EUNCHA P | — | §102§103 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18690014 | GENETIC RESISTANCE TO VIRAL DISEASE IN SALMONID FISH | BURKHART, MICHAEL D | 1638 | §112 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18580909 | METHOD OF SELECTIVE PRECIPITATION OF METALS USING AMIDE COMPOUNDS | PULLEN, NIKOLAS TAKUYA | 1733 | §103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18568921 | GRANZYME B DETECTION | BOWLES, DAVID PAUL | 1653 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18274306 | FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD | JOHANSEN, PETER N. | 1644 | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18010440 | ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE, PIOGLITAZONE OR ROSIGLITAZONE | MCANANY, JOHN D | 1625 | §103 | Non-Final OA | — | Pending | Dec 14, 2022 |
| 17638542 | PARASITIC NEMATODE VACCINE | OGUNBIYI, OLUWATOSIN A | 1645 | §112 | Non-Final OA | — | Pending | Feb 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial